Posts tagged "clinical development startup"

Biotech startup Inflazome has raised $63 million to commercialise its drug slowing the progress of inflammatory diseases like Alzheimer’s and Parkinson’s.

Biotech startup Paragen Bio has launched with an initial $6 million investment to continue medical developments using secretions from parasitic hookworms.